{"id":769102,"date":"2025-10-16T12:10:01","date_gmt":"2025-10-16T12:10:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=769102"},"modified":"2025-10-16T12:10:01","modified_gmt":"2025-10-16T12:10:01","slug":"global-digital-biomarkers-market-set-to-grow-at-17-cagr-by-2032-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-digital-biomarkers-market-set-to-grow-at-17-cagr-by-2032-delveinsight_769102.html","title":{"rendered":"Global Digital Biomarkers Market Set to Grow at ~17% CAGR by 2032 | DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/upload\/2025\/10\/1760578788.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Global Digital Biomarkers Market Set to Grow at ~17% CAGR by 2032 | DelveInsight\" src=\"https:\/\/www.abnewswire.com\/upload\/2025\/10\/1760578788.jpg\" alt=\"Global Digital Biomarkers Market Set to Grow at ~17% CAGR by 2032 | DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Global Digital Biomarkers Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Digital Biomarkers Companies are BioSensics, AliveCor, Eyenuk, Quibim, Huma, Evidation Health, Oura Health, Biobeat, Omada Health, F. Hoffmann-La Roche, Koneksa Health, Altoida, Empatica, VivoSense, IXICO, Proscia, Agenus, Lunit, BostonGene, PathAI, and others.<\/div>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s <strong>Digital Biomarkers Market Insights Report<\/strong> offers comprehensive coverage of current and future market trends, competitive dynamics, growth drivers, barriers, and strategic developments across the sector.<\/p>\n<p style=\"text-align: justify;\">The use of digital biomarkers is accelerating worldwide, driven by the rising prevalence of chronic diseases such as cardiovascular, neurological, and metabolic disorders. Aging populations&mdash;who are more prone to such conditions&mdash;are further boosting demand, while the growing adoption of wearable technologies and continuous innovation from market leaders is fueling market expansion at an unprecedented pace.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Download the Full Digital Biomarkers Market Outlook &amp; Stay Ahead of 17% CAGR Growth &ndash; <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/digital-biomarkers-market?utm_source=openpr&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Global Digital Biomarkers Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key Digital Biomarkers Market Highlights<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>North America<\/strong> is expected to lead the global digital biomarkers market throughout the forecast period.<\/li>\n<li>In 2024, <strong>physiological biomarkers<\/strong> accounted for the largest segment share.<\/li>\n<li>The market features prominent digital biomarker companies such as BioSensics, AliveCor, Eyenuk, Quibim, Huma, Evidation Health, Oura Health, Biobeat, Omada Health, F. Hoffmann-La Roche, Koneksa Health, Altoida, Empatica, VivoSense, IXICO, Proscia, Agenus, Lunit, BostonGene Corporation, PathAI, and others.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Recent Strategic Collaborations in Digital Biomarkers<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>June 2025:<\/strong> Agenus and Noetik partnered to develop AI-enabled predictive biomarkers for BOT\/BAL using virtual cell biology models to personalize immunotherapy.<\/li>\n<li><strong>March 2025:<\/strong> Lunit teamed up with the U.S. National Cancer Institute (NCI) to advance AI-driven digital biomarkers for tumor microenvironment and immune phenotyping in cancer research.<\/li>\n<li><strong>March 2025:<\/strong> BostonGene initiated AI-based molecular profiling initiatives to explore colorectal cancer and multiple myeloma biomarkers through clinical trials.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Explore Strategic Opportunities with Leading Digital Biomarker Innovators &#8211; Access the Report Now &#8211; <\/strong><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/digital-biomarkers-market?utm_source=openpr&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Digital Biomarkers Market Forecast<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>What Are Digital Biomarkers?<\/strong><\/p>\n<p style=\"text-align: justify;\">Digital biomarkers involve measurable physiological or behavioral data collected using digital devices such as smartphones, wearables, or biosensors. Unlike traditional lab-based biomarkers, they enable remote, real-time, and continuous monitoring of health indicators, including:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Heart rate variability<\/li>\n<li>Sleep cycles<\/li>\n<li>Gait characteristics<\/li>\n<li>Voice tone<\/li>\n<li>Typing patterns<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">These technologies provide deeper visibility into disease progression, treatment response, and daily health patterns outside clinical environments. Their use is expanding across clinical trials, precision medicine, and chronic disease monitoring.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Tap into North America&rsquo;s Dominance &#8211; Get Regional Insights &amp; Competitive Intelligence &#8211; <\/strong><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/digital-biomarkers-market?utm_source=openpr&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Digital Biomarkers Competitive Landscape<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Digital Biomarkers Market Insights &amp; Regional Leadership<\/strong><\/p>\n<p style=\"text-align: justify;\">North America holds a dominant market position due to:<\/p>\n<ul style=\"text-align: justify;\">\n<li>High chronic disease burden<\/li>\n<li>A growing elderly population<\/li>\n<li>Broad use of wearables and connected health devices<\/li>\n<li>Continuous product innovation and timely regulatory support<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">These factors collectively reinforce the region&rsquo;s leadership in digital biomarker adoption and commercialization.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key Digital Biomarkers Market Dynamics<\/strong><\/p>\n<p style=\"text-align: justify;\">The market&rsquo;s rapid progression is being shaped by:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Increased integration of wearables and connected health platforms<\/li>\n<li>Growing emphasis on real-time health tracking and preventive care<\/li>\n<li>Adoption in clinical trials for adherence monitoring, patient stratification, and real-world evidence generation<\/li>\n<li>Supportive regulatory frameworks and evolving FDA guidance on digital health<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">However, challenges such as interoperability, data privacy, device standardization, and secure data management persist. To address these, companies are investing in AI-powered analytics, cloud platforms, and cross-industry partnerships.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Unlock AI-Driven Biomarker Trends &amp; Partnerships &#8211; Request Your Market Brief Today &#8211; <\/strong><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/digital-biomarkers-market?utm_source=openpr&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Digital Biomarkers Market Trends<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Digital Biomarkers Future Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">Innovation in sensors, machine learning, virtual monitoring tools, and mobile health apps is expanding digital biomarker applications into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Mental health<\/li>\n<li>Oncology<\/li>\n<li>Neurology<\/li>\n<li>Autoimmune and metabolic diseases<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Organizations that offer scalable, secure, interoperable technologies are projected to gain a strong competitive edge in this evolving landscape.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Digital Biomarkers Market Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Digital Biomarkers Market By Product Type:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Wearable Devices<\/li>\n<li>Implantable Devices<\/li>\n<li>Software\/Applications<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Digital Biomarkers Market By Biomarker Type:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Physiological<\/li>\n<li>Behavioral<\/li>\n<li>Biochemical<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Digital Biomarkers Market By Indication:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Neurological<\/li>\n<li>Cardiovascular<\/li>\n<li>Metabolic<\/li>\n<li>Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Digital Biomarkers Market By Application:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Diagnostic<\/li>\n<li>Monitoring<\/li>\n<li>Predictive<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Digital Biomarkers Market By Region:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>North America Digital Biomarkers Market<\/li>\n<li>Europe Digital Biomarkers Market<\/li>\n<li>Asia-Pacific Digital Biomarkers Market<\/li>\n<li>Rest of World Digital Biomarkers Market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Discover Segment-Wise Growth across Wearables, Diagnostics &amp; Predictive Biomarkers &#8211; Get the Full Analysis &#8211; <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/digital-biomarkers-market?utm_source=openpr&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Digital Biomarkers Market Size and Forecasts<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Digital Biomarkers Market Overview at a Glance<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Study Period:<\/strong> 2022&ndash;2032<\/li>\n<li><strong>CAGR: <\/strong>~17%<\/li>\n<li><strong>Forecasted Market Size (2032): <\/strong>~USD 14 Billion<\/li>\n<li><strong>Coverage: <\/strong>Global<\/li>\n<li><strong>Key Companies: <\/strong>BioSensics, AliveCor, Eyenuk, Quibim, Huma, Evidation Health, Oura Health, Biobeat, Omada Health, F. Hoffmann-La Roche, Koneksa Health, Altoida, Empatica, VivoSense, IXICO, Proscia, Agenus, Lunit, BostonGene, PathAI, and others.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=global-digital-biomarkers-market-set-to-grow-at-17-cagr-by-2032-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +14699457679<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/consulting\/conference-coverage-services\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/consulting\/conference-coverage-services<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=global-digital-biomarkers-market-set-to-grow-at-17-cagr-by-2032-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Global Digital Biomarkers Market Digital Biomarkers Companies are BioSensics, AliveCor, Eyenuk, Quibim, Huma, Evidation Health, Oura Health, Biobeat, Omada Health, F. Hoffmann-La Roche, Koneksa Health, Altoida, Empatica, VivoSense, IXICO, Proscia, Agenus, Lunit, BostonGene, PathAI, and others. DelveInsight&rsquo;s Digital Biomarkers Market &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/global-digital-biomarkers-market-set-to-grow-at-17-cagr-by-2032-delveinsight_769102.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,420,413],"tags":[],"class_list":["post-769102","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/769102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=769102"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/769102\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=769102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=769102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=769102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}